Major interaction on record — check this product against your medications before combining. Check your meds →
Dietary supplement

Alpha Yohimbine Ingredients & Drug Interactions

by T6 Team Six

Alpha Yohimbine label
See full label image
Capsule Category: Botanical
Most serious interaction: Major
Clinical methodology reviewed by · Updated Sep 30, 2026 · Label data from the NIH DSLD
What is this page for?

First and foremost: checking Alpha Yohimbine against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.

Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy

The interaction bottom line Most serious interaction: Major

Alpha Yohimbine is a dietary supplement by T6 Team Six with 1 active ingredient. Its ingredients are commonly taken for high blood pressure, anxiety and agitation, sleep problems.Based on those ingredients, 840 medications have a known interaction with it, the most serious rated major. The ingredients most likely to interact are Rauwolfia vomitoria. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

Jump to a section

Check Your Meds Against Alpha Yohimbine by T6 Team Six

Ask about any prescription or over-the-counter medication and we check it for interactions with Alpha Yohimbine by T6 Team Six — and tell you which ingredient is responsible.

Pharmacist-reviewed data Checks every ingredient Answer in seconds
Prefer a human? Send your question to our licensed pharmacists — free, answered by email within 24 hours.

HelloPharmacist Scorecard of Alpha Yohimbine by T6 Team Six

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

Generated from HelloPharmacist’s pharmacist-curated databases and editorial rules · Last generated Jul 11, 2026

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 1 of its 1 active ingredient.
  • No proprietary blends here — you can verify the dose of every single component.

Alpha Yohimbine is a single-ingredient capsule: rauwolfia vomitoria, a plant extract that contains potent alkaloids, including yohimbine and reserpine. The capsule itself is made from hypromellose and cellulose, with ascorbyl palmitate as an added inactive ingredient.

Does it work?

Not established
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not established

The graded evidence we hold for these ingredients covers different conditions than the ones this product is marketed for, so there's no established rating for its stated use — see Rauvolfia Vomitoria's own graded uses on its monograph.

Why this rating?
  • The label markets this product for: fat burning, focus, and healthy libido.
  • We looked for evidence on: Athletic performance, Weight management, Cognitive function, Sexual function.
  • The closest evidence on file: Rauvolfia Vomitoria is rated "Insufficient Reliable Evidence To Rate" for Athletic performance (Natural Medicines).

The evidence for rauwolfia vomitoria in this product isn't established. We have no reliable data rating it for athletic performance, diabetes management, or psychosis.

If you're considering this product for any of those purposes, talk to your pharmacist about whether the science supports it.

The evidence, ingredient by ingredient Rauvolfia Vomitoria

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Rauwolfia vomitoria is possibly unsafe taken by mouth due to potent alkaloids that can cause serious effects — low blood pressure, depression, and rare movement disorders like akathisia and tremor. The product safety data advises against use during pregnancy and while breastfeeding, since alkaloids may pass into breast milk and safety is unknown.

Because this ingredient contains small amounts of reserpine and yohimbine, it carries a real risk of adverse effects even at standard doses.

Side effects, ingredient by ingredient Rauvolfia Vomitoria

Meds to double-check

Major interaction found
Known Interaction Concern · database check
Major identified

At least one ingredient has a documented Major-severity interaction. Check your medications for a personalized result.

Why this rating?
  • 1 of the 1 matched ingredient can interact with medications — Rauvolfia Vomitoria.
  • The most serious interaction on file is rated Major.
  • Some involve high-stakes drug classes: anticoagulant / antiplatelet drugs; diabetes medications; Parkinson's medications.
  • For scale: 840 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before you take Alpha Yohimbine, run these medication types through the checker on this page: antipsychotic drugs, stimulants, levodopa, MAO inhibitor antidepressants (Major severity interactions), and blood pressure medications, diabetes drugs, and liver enzyme substrates like certain antidepressants and pain relievers (Moderate severity). The ingredient has documented interactions with a large number of individual medications across these categories.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with no established evidence rating for its marketed use. Major medication interactions have been identified, and safety information is well characterized.

Alpha Yohimbine is a potent, single-ingredient supplement with significant documented interactions and serious safety concerns. If you take any antipsychotic, antidiabetes, blood pressure, or stimulant medication — or an MAOI antidepressant — you should check with your pharmacist before considering this product.

Pregnant people and those breastfeeding should avoid it entirely. Anyone interested in this supplement should discuss it with their pharmacist first.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Feb 25, 2019.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Alpha Yohimbine, straight from the product label.

Brand T6 Team Six
Net contents 60 Veggie Cap(s)
Market status On market
Date entered into DSLD Feb 25, 2019
DSLD ID 190976
Product type Botanical
Supplement form Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Alpha Yohimbine by T6 Team Six, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Vcap(s)
Maximum serving Sizes:
1 Vcap(s)
Servings per container
60
IngredientAmount% DV
Rauwolfia vomitoria2 mg--

Other ingredients: Hypromellose, Cellulose, Ascorbyl Palmitate

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Suggested/Recommended/Usage/Directions

Suggested use: As a dietary supplement take 1 capsule 1-2 times per day. Do not take within 6 hours of bedtime.

Precautions

Do not take within 6 hours of bedtime.

Warning: Not intended for use by persons under age 18.

Do not exceed recommended dose. Do not take for more than 8 consecutive weeks.

This product should not be taken by pregnant or lactating women. Get the consent of a licensed physician before using this product, especially if you are taking medication, have a medical condition, or thinking about becoming pregnant.

Caution should be taken when consuming with caffeinated products. Do not consume with products in excess of 200 mg of caffeine.

Keep this product and all supplements out of the reach of children.

Formula

Alpha Yohimbine is designed to help promote: Fat burning potential Increased focus Healthy libido

Premium Rauwolscine

2 mg Rauwolfia vomitoria (Alpha Yohimbine)

Yohimbine works by increasing adrenaline levels in the body, as well as inhibiting a regulatory process in fat cells, which normally suppresses fat burning.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to treat, diagnose, cure or prevent any disease.

General Statements

We support our troops

Fat-burning compound, primarily used to lose fat during short term fasting.

Clinically dosed

Seals/Symbols

Third Party Tested

No Hidden Ingredients

GMP

3rd Party Tested

FDA Statement of Identity

Dietary Supplement

Is this label outdated? Report a formula or label change and our pharmacy team will review it.

See for yourself

Alpha Yohimbine by T6 Team Six label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

Alpha Yohimbine label

Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.

View the full label (PDF)
What’s inside

The Ingredients in Alpha Yohimbine by T6 Team Six

This is the 1 active ingredient this product is made of. Select it to open its full monograph.

Serving size1 Vcap(s) Dosage formCapsule Servings per container60 Amounts shown are per serving.

Rauwolfia vomitoria

Interacts with
840 drugs
2 mg per serving Form: Alpha Yohimbine

Rauvolfia vomitoria is an African shrub whose root contains powerful alkaloids, including reserpine, that have historically been used for high blood p...

Rauwolfia vomitoria monograph & interactions

Other (inactive) ingredients: Hypromellose, Cellulose, Ascorbyl Palmitate. These complete the product’s ingredient list but are not active constituents.

Interaction report

Alpha Yohimbine by T6 Team Six Drug Interactions

Want to check YOUR meds against Alpha Yohimbine?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

 Go to the checker
840Drugs
230 Major 523 Moderate 87 Minor

Ingredients driving the most interactions

Rauwolfia vomitoria 840

Individual Drug Interactions

The ingredients in Alpha Yohimbine interact with 840 drugs. Click any drug to see the details.

1 of the 1 ingredient in Alpha Yohimbine interact with drugs. Each result below shows which ingredient is responsible. Rauwolfia vomitoria

Each ingredient & the kinds of drugs it affects

For each ingredient in Alpha Yohimbine with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

Rauwolfia vomitoria11 drug types · 840 drugs

Antipsychotic Drugs

Theoretically, concomitant use might increase the risk of adverse effects.
Concomitant use of neuroleptics with Rauvolfia vomitoria may potentiate the effects of these drugs and the rauwolfia alkaloids.

Likelihood Probable Evidence D
Levodopa

Theoretically, Rauvolfia vomitoria might reduce the effects of levodopa.
Avoid using Rauvolfia vomitoria with levodopa; concomitant use may reduce drug effectiveness and increase extrapyramidal motor symptoms.

Likelihood Probable Evidence D
Monoamine Oxidase Inhibitors (Maois)

Theoretically, concomitant use might cause additive effects.
Yohimbine, a constituent of Rauvolfia vomitoria, has MAO inhibitory effects. At high doses, yohimbine is a non-selective inhibitor of MAO.

Likelihood Probable Evidence D
Stimulant Drugs

Theoretically, concomitant use might cause additive effects.
Yohimbine, a constituent of Rauvolfia vomitoria, has sympathomimetic effects and increases blood pressure in a dose-dependent manner. Theoretically, taking Rauvolfia vomitoria with stimulant drugs can have additive stimulant and hypertensive effects.

Likelihood Probable Evidence D
Antidiabetes Drugs

Theoretically, taking Rauvolfia vomitoria with antidiabetes drugs might increase the risk of hypoglycemia.
Preliminary clinical research shows that drinking a beverage containing Rauvolfia vomitoria foliage and bitter orange fruit lowers blood glucose levels. Hypoglycemic effects of Rauvolfia vomitoria have also been demonstrated in an animal diabetic model.

Likelihood Possible Evidence D
Antihypertensive Drugs

Theoretically, Rauvolfia vomitoria might increase the risk of hypotension.
Rauvolfia vomitoria contains a very small amount of the drug reserpine. Reserpine can reduce both systolic and diastolic blood pressure.

Likelihood Possible Evidence D
Cns Depressants

Theoretically, taking Rauvolfia vomitoria might cause additive sedative effects.
Rauvolfia vomitoria has sedative effects in animal research.

Likelihood Possible Evidence D
Cytochrome P450 2D6 (Cyp2D6) Substrates

Theoretically, Rauvolfia vomitoria might increase the levels and clinical effects of CYP2D6 substrates.
Rauvolfia vomitoria contains small amounts of the drug yohimbine. In vitro research shows that yohimbine inhibits CYP2D6 enzyme activity.

Likelihood Possible Evidence D
Ephedrine

Theoretically, Rauvolfia vomitoria might alter the effects and side effects of ephedrine.
Rauvolfia vomitoria contains resperine, which might reduce indirect-sympathomimetic drug activity. However, another constituent of Rauvolfia vomitoria, yohimbine, has stimulant activity and may increase the risk of adverse effects with ephedrine.

Likelihood Probable Evidence D
Tricyclic Antidepressants (Tcas)

Theoretically, concomitant use might alter the effects of Rauvolfia vomitoria and increase the risk for adverse effects.
A small clinical study in patients taking TCAs for at least 4 weeks shows that receiving doses of intravenous yohimbine, a constituent of Rauvolfia vomitoria, 2.5-20 mg daily for up to 7 days precipitates severe anxiety, agitation, and tremor. Also, concomitant use of TCAs with Rauvolfia vomitoria may decrease the effects of rauwolfia alkaloids.

Likelihood Probable Evidence D
Anticoagulant/Antiplatelet Drugs

Theoretically, combining Rauvolfia vomitoria with antiplatelet or anticoagulant drugs might have additive effects.
Rauvolfia vomitoria contains small amounts of yohimbine. Research in healthy adults shows that taking yohimbine in doses of 8 mg or more seems to inhibit platelet aggregation in vitro by binding to the alpha-2 adrenoceptor. The effects of Rauvolfia vomitoria itself are unclear.

Likelihood Possible Evidence D
Rauwolfia vomitoria full monograph & interactions
The maker

Brand information

Manufacturer and brand details for Alpha Yohimbine, from the product label.

T6 Team Six

See all T6 Team Six products
Name
Team Six Supplements
City
Alpharetta
State
GA
ZipCode
30005
Web Address
www.t6supplements.com
Pharmacist Counseling Corner

Alpha Yohimbine by T6 Team Six: Common Questions

Does Alpha Yohimbine by T6 Team Six interact with any medications?
Yes. Based on its ingredients, Alpha Yohimbine has a known interaction with 840 medications, including 230 rated major. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Alpha Yohimbine contains a single active ingredient, and that one ingredient can interact with many different medications on its own. We check it against each medication and show the mechanism responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
What's actually in this capsule?
One active ingredient: rauwolfia vomitoria, a plant extract with powerful alkaloids including yohimbine and reserpine. The capsule walls are hypromellose and cellulose, with ascorbyl palmitate added.
Does it really work for athletic performance or building muscle?
We don't have reliable evidence to rate it for athletic performance. If that's why you're looking at this product, talk to your pharmacist about whether the science backs it up.
Can I take it if I'm on blood pressure medication?
Rauwolfia vomitoria may lower your blood pressure further, so it's not a straightforward yes. You must check your specific medication with the tool on this page and talk to your pharmacist before starting.
What are the side effects I should watch for?
This ingredient is possibly unsafe because of its potent alkaloids. Serious but rare effects include movement problems like tremor and akathisia. Low blood pressure and depression are also possible. Since it contains reserpine, you may also experience drowsiness, fatigue, or nightmares.
Is it safe to use while pregnant or nursing?
No — the safety data advises against it during pregnancy due to the potent alkaloids and lack of safety studies. While breastfeeding, alkaloids may pass into milk and safety is unknown, so it should be avoided then too.
Can I take this with an SSRI antidepressant?
Rauwolfia vomitoria may block a liver enzyme that clears certain antidepressants, raising their levels in your blood. You must check your exact medication with the checker on this page before taking this product.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Alpha Yohimbine is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Alpha Yohimbine label
Go deeper

The Full Monographs Behind Alpha Yohimbine’s Ingredients

Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.

Herb & supplement monograph

Rauvolfia Vomitoria

Interacts with 840 drugs

Rauvolfia vomitoria is an African shrub whose root contains powerful alkaloids, including reserpine, that have historically been used for high blood pressure and agitation. Because these com...

Read the full Rauvolfia Vomitoria monograph →
Sources

Sources & How We Checked

Alpha Yohimbine's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 46 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Rauvolfia Vomitoria 46 references
  1. Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
  2. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.
  3. McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
  4. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  5. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
  6. Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol 1980;60:85-7.
  7. Teloken C, Rhoden EL, Sogari P, et al. Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction. J Urol 1998;159:122-4. PubMed
  8. Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992;53:119-22.
  9. Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry 1992;53:207-9.
  10. Sandler B, Aronson P. Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urol 1993;41:343-5. PubMed
  11. Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother 2010;44:1022-9. PubMed
  12. Chapotin SM, Razanameharizaka JH, Holbrook NM. A biomechanical perspective on the role of large stem volume and high water content in baobab trees (Adansonia spp.; Bombacaceae). Am J Bot 2006;93:1251-64.
  13. VandenBrink, B. M., Foti, R. S., Rock, D. A., Wienkers, L. C., and Wahlstrom, J. L. Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition. Drug Metab Dispos. 2012;40(1):47-53. PubMed
  14. Campbell-Tofte, J. I., Molgaard, P., Josefsen, K., Abdallah, Z., Hansen, S. H., Cornett, C., Mu, H., Richter, E. A., Petersen, H. W., Norregaard, J. C., and Winther, K. Randomized and double-blinded pilot clinical study of the safety and anti-diabetic ef
  15. Mustonen, P., Savola, J., and Lassila, R. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine. Thromb.Res 8-1-2000;99(3):231-237.
  16. Bagheri, H., Schmitt, L., Berlan, M., and Montastruc, J. L. Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants. Br J Clin Pharmacol 1992;34(6):555-558. PubMed
  17. Adeniyi, A. A., Brindley, G. S., Pryor, J. P., and Ralph, D. J. Yohimbine in the treatment of orgasmic dysfunction. Asian J Androl 2007;9(3):403-407. PubMed
  18. Giampreti, A., Lonati, D., Locatelli, C., Rocchi, L., and Campailla, M. T. Acute neurotoxicity after yohimbine ingestion by a body builder. Clin Toxicol.(Phila) 2009;47(8):827-829. PubMed
  19. Myers, A. and Barrueto, F., Jr. Refractory priapism associated with ingestion of yohimbe extract. J Med Toxicol. 2009;5(4):223-225.
  20. Berlin, I., Crespo-Laumonnier, B., Cournot, A., Landault, C., Aubin, F., Legrand, J. C., and Puech, A. J. The alpha 2-adrenergic receptor antagonist yohimbine inhibits epinephrine-induced platelet aggregation in healthy subjects. Clin Pharmacol.Ther. 199
  21. Cimolai, N. and Cimolai, T. Yohimbine use for physical enhancement and its potential toxicity. J Diet.Suppl 2011;8(4):346-354. PubMed
  22. Landis, E. and Shore, E. Yohimbine-induced bronchospasm. Chest 1989;96(6):1424. PubMed
  23. Susset, J. G., Tessier, C. D., Wincze, J., Bansal, S., Malhotra, C., and Schwacha, M. G. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol. 1989;141(6):1360-1363. PubMed
  24. Charney, D. S., Price, L. H., and Heninger, G. R. Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action. Arch.Gen.Psychiatry 1986;43(12):1155-1161. PubMed
  25. Braddock, L., Cowen, P. J., Elliott, J. M., Fraser, S., and Stump, K. Binding of yohimbine and imipramine to platelets in depressive illness. Psychol.Med 1986;16(4):765-773. PubMed
  26. Charney, D. S., Heninger, G. R., and Sternberg, D. E. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine. Life Sci 6-7-1982;30(23):2033-2041.
  27. Boon, N. A., Elliott, J. M., Grahame-Smith, D. G., John-Green, T., and Stump, K. A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]- dihydroergocryptine. J Auton.Pharmacol 1983;3
  28. Morgan, C. A., III, Southwick, S. M., Grillon, C., Davis, M., Krystal, J. H., and Charney, D. S. Yohimbine-facilitated acoustic startle reflex in humans. Psychopharmacology (Berl) 1993;110(3):342-346. PubMed
  29. Mann, K., Klingler, T., Noe, S., Roschke, J., Muller, S., and Benkert, O. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch.Sex Behav. 1996;25(1):1-16. PubMed
  30. Rowland, D. L., Kallan, K., and Slob, A. K. Yohimbine, erectile capacity, and sexual response in men. Arch Sex Behav 1997;26(1):49-62.
  31. Riley AJ, Goodman R, Kellett JM, and et al. Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy. Sexual Marital Ther 1989;4(1):17-26. DOI
  32. Ruck B, Shih RD, Marcus SM. Hypertensive crisis from herbal treatment of impotence. Am J Emerg Med. 1999;17:317-318. PubMed
  33. Eluwa MA, Udoaffah MT, Vulley MB, et al. Comparative study of teratogenic potentials of crude ethanolic root bark and leaf extract of Rauwolfia vomitoria (apocynaceae) on the fetal heart. N Am J Med Sci 2010;2:592-5. PubMed
  34. Eluwa MA, Ekanem TB, Udoh PB, et al. Teratogenic effect of crude ethanolic root bark and leaf extracts of Rauwolfia vomitoria (Apocynaceae) on nissl substances of albino wistar rat fetuses. Neurosci J 2013;2013:906731.
  35. Eluwa MA, Ekanem TB, Udoh PB, et al. Teratogenic effect of crude ethanolic root bark and leaf extracts of Rauwolfia vomitoria (Apocynaceae) on the femur of albino wistar rat fetuses. J. Histol 2013;1-5.
  36. Ekong MB, Peter AI, Edagha IA, et al. Rauwolfia vomitoria inhibits olfaction and modifies olfactory bulb cells. Brain Res Bull 2016;124:206-13. PubMed
  37. Amole OO, Yemitan OK, Oshikoya KA. Anticonvulsant activity of Rauvol?a Vomitoria (Afzel). Afr J Pharmacy Pharmacol 2009;3:319-322.
  38. Campbell JI, Mortensen A, Mølgaard P. Tissue lipid lowering-effect of a traditional Nigerian anti-diabetic infusion of Rauwolfia vomitoria foilage and Citrus aurantium fruit. J Ethnopharmacol 2006;104:379-86. PubMed
  39. Wylie KR. Yohimbine and sinusitis. Br J Psychiatry. 1996;169(3):384-5. PubMed
  40. Lobay D. Rauwolfia in the Treatment of Hypertension. Integr Med (Encinitas). 2015 Jun;14(3):40-6.
  41. Sheldon MB, Kotte JH. Effect of Rauwolfia serpentina and reserpine on the blood pressure in essential hypertension; a long-term double-blind study. Circulation. 1957 Aug;16(2):200-6.
  42. Vakil RJ. A clinical trial of Rauwolfia serpentina in essential hypertension. Br Heart J. 1949 Oct;11(4):350-5. PubMed
  43. Obembe A, Sokomba EN, Sijuwola OA, et al. Antipsychotic effects and tolerance of crude Rauvolfia vomitoria in Nigerian psychiatric inpatients. Phytotherapy Research. 1994;8(4):218-23.
  44. Bharucha AE, Skaar T, Andrews CN, et al Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil. 2008;20(8):891-9. PubMed
  45. Schmauss M, Laakmann G, Dieterle D. Effects of alpha 2-receptor blockade in addition to tricyclic antidepressants in therapy-resistant depression. J Clin Psychopharmacol. 1988;8(2):108-11.
  46. Wang N, Xie YW, Li MY, et al. Simultaneous determination of five alkaloids from Rauvolfia vomitoria in rat plasma by LC-MS/MS: Application to a comparative pharmacokinetic study in normal and type 2 diabetic rats. J Sep Sci 2021;44(7):1391-1403.

See these in context on the Rauvolfia Vomitoria monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Supplement interaction checker › Check any supplement or product against your medications Drug–drug interactions › Check two or more of your medications against each other Browse medications A–Z › Every drug we've checked against herbs & supplements NDC & pricing lookup › Find a drug’s NDCs, packaging and costs Ask a pharmacist › Free, personal answer from our licensed team